The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that the Company has signed non-binding Letters of Intent (LOI’s) to acquire up to four cannabis enterprises in Arizona and Maryland.

he main task of the EFMD is to resolve issues related to business education, as well as to help develop educational institutions.

ABB reduces operational costs of Italian water company with energy management solution by 30 percent.

Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients Under 13 Years of Age

Today at its Financial Analyst Day, AMD (NASDAQ:AMD) detailed the next phase of its long-term growth strategy focused on delivering products and technologies for a combined $60 billion market for PCs, immersive devices, and datacenters.